Welcome to LookChem.com Sign In|Join Free
  • or
6-(3-carboxypropyl)-2,3-diMethoxy-5-Methyl-1,4-benzoquinone is a chemical compound with the molecular formula C13H18O5. It is a derivative of 1,4-benzoquinone, a natural compound found in various plants. 6-(3-carboxypropyl)-2,3-diMethoxy-5-Methyl-1,4-benzoquinone features two methoxy groups and a methyl group attached to the benzoquinone core, along with a carboxypropyl group. It is utilized in the synthesis of pharmaceuticals and serves as an intermediate in organic chemistry. Additionally, it exhibits potential biological activity and is under investigation for its possible medical applications, particularly in addressing neurological disorders and cancer.

58186-01-9

Post Buying Request

58186-01-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

58186-01-9 Usage

Uses

Used in Pharmaceutical Synthesis:
6-(3-carboxypropyl)-2,3-diMethoxy-5-Methyl-1,4-benzoquinone is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows for the development of new drugs with potential therapeutic benefits.
Used in Organic Chemistry:
As an intermediate in organic chemistry, 6-(3-carboxypropyl)-2,3-diMethoxy-5-Methyl-1,4-benzoquinone plays a crucial role in the formation of complex organic molecules, contributing to the advancement of chemical research and the creation of novel compounds.
Used in Medical Research:
6-(3-carboxypropyl)-2,3-diMethoxy-5-Methyl-1,4-benzoquinone is being studied for its potential medical applications, particularly in the treatment of neurological disorders. Its biological activity suggests that it may have a positive impact on the management or treatment of such conditions.
Used in Cancer Research:
6-(3-carboxypropyl)-2,3-diMethoxy-5-Methyl-1,4-benzoquinone is also being explored for its potential role in cancer treatment. Its biological activity indicates that it may contribute to the development of new therapeutic strategies against various types of cancer.

Check Digit Verification of cas no

The CAS Registry Mumber 58186-01-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,1,8 and 6 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 58186-01:
(7*5)+(6*8)+(5*1)+(4*8)+(3*6)+(2*0)+(1*1)=139
139 % 10 = 9
So 58186-01-9 is a valid CAS Registry Number.

58186-01-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,3-dimethoxy-5-methyl-6-(3'-carboxypropyl)-1,4-benzoquinone

1.2 Other means of identification

Product number -
Other names 2,3-Dimethoxy-5-methyl-6-(3-carboxypropyl)-1,4-benzochinon

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:58186-01-9 SDS

58186-01-9Relevant academic research and scientific papers

Bioactivity profiles of cytoprotective short-chain quinones

Chear, Sueanne,Feng, Zikai,Gueven, Nuri,Hemasa, Ayman L.,Nadikudi, Monila,Smith, Jason A.,Woolley, Krystel L.

supporting information, (2021/05/31)

Short-chain quinones (SCQs) have been investigated as potential therapeutic candidates against mitochondrial dysfunction, which was largely thought to be associated with the reversible redox characteristics of their active quinone core. We recently reported a library of SCQs, some of which showed potent cytoprotective activity against the mitochondrial complex I inhibitor rotenone in the human hepatocarcinoma cell line HepG2. To better characterize the cytoprotection of SCQs at a molecular level, a bioactivity profile for 103 SCQs with different compound chemistries was generated that included metabolism related markers, redox activity, expression of cytoprotective proteins and oxidative damage. Of all the tested endpoints, a positive correlation with cytoprotection by SCQs in the presence of rotenone was only observed for the NAD(P)H:quinone oxidoreductase 1 (NQO1)-dependent reduction of SCQs, which also correlated with an acute rescue of ATP levels. The results of this study suggest an unexpected mode of action for SCQs that appears to involve a modification of NQO1-dependent signaling rather than a protective effect by the reduced quinone itself. This finding presents a new selection strategy to identify and develop the most promising compounds towards their clinical use.

Aralkyl carboxylic acid compounds

-

, (2008/06/13)

Novel compounds of the formulae STR1 wherein R represents lower alkyl or lower alkoxy, A represents --CH2 --, --CO-- or STR2 n represents an integer of 1 to 8, X represents hydrogen or hydroxyl which may be protected and Y represents hydroxyl which may be protected, and their esters show an excellent action on the lysosomal membranes of cells, and exhibit excellent pharmacological activities such as physiologic host defense control activity, especially immuno-potentiating activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 58186-01-9